HMGA2 promotes nasopharyngeal carcinoma progression and is associated with tumor resistance and poor prognosis

被引:2
|
作者
Ouyang, Xinting [1 ]
Li, Kangxin [1 ]
Wang, Jiaqi [1 ]
Zhu, Weijian [1 ]
Yi, Qiang [1 ]
Zhong, Jinghua [2 ]
机构
[1] Gannan Med Univ, Ganzhou, Jiangxi, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Oncol, Ganzhou, Jiangxi, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 13卷
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; HMGA2; invasion metastasis; tumor resistance; prognosis; EPITHELIAL-MESENCHYMAL TRANSITION; GROUP-A PROTEINS; TRANSCRIPTIONAL ACTIVATION; E-CADHERIN; CANCER; AUTOPHAGY; STEM; GENE; EMT; EXPRESSION;
D O I
10.3389/fonc.2023.1271080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasopharyngeal carcinoma (NPC), as one of the most prevalent malignancies in the head and neck region, still lacks a complete understanding of its pathogenesis. Presently, radiotherapy, concurrent chemoradiotherapy, and targeted therapy stand as the primary modalities for treating NPC. With advancements in medicine, the cure rates for nasopharyngeal carcinoma have been steadily increasing. Nevertheless, recurrence and metastasis persist as the primary reasons for treatment failure. Consequently, a profound exploration of the molecular mechanisms underlying the occurrence and progression of nasopharyngeal carcinoma, along with the exploration of corresponding therapeutic approaches, becomes particularly imperative in the quest for comprehensive solutions to combat this disease. High mobility group AT-hook 2 (HMGA2) is a pivotal protein capable of altering chromatin structure, regulating gene expression, and influencing transcriptional activity. In the realm of cancer research, HMGA2 exhibits widespread dysregulation, playing a crucial role in nearly all malignant tumors. It is implicated in various tumorigenic processes, including cell cycle regulation, cell proliferation, epithelial-mesenchymal transition, angiogenesis, tumor invasion, metastasis, and drug resistance. Additionally, HMGA2 serves as a molecular marker and an independent prognostic factor in certain malignancies. Recent studies have increasingly unveiled the critical role of HMGA2 in nasopharyngeal carcinoma (NPC), particularly in promoting malignant progression, correlating with tumor resistance, and serving as an independent adverse prognostic factor. This review focuses on elucidating the oncogenic role of HMGA2 in NPC, suggesting its potential association with chemotherapy resistance in NPC, and proposing its candidacy as an independent factor in nasopharyngeal carcinoma prognosis assessment.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma
    Tang, Yan
    Yang, Xuefeng
    Feng, Kehai
    Hu, Changlu
    Li, Suyi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (01) : 174 - 183
  • [22] Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma
    Zhang, Qi
    Wu, Junxiu
    Chen, Xinpeng
    Zhao, Ming
    Zhang, Dahong
    Gao, Feng
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [23] High expression of agrin is associated with tumor progression and poor prognosis in hepatocellular carcinoma
    Zhang, Qi-Jia
    Wan, Li
    Xu, Han-Feng
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2019, 16 (06) : 7375 - 7383
  • [24] HMGA2 Is a Driver of Tumor Metastasis
    Morishita, Asahiro
    Zaidi, M. Raza
    Mitoro, Akira
    Sankarasharma, Devipriya
    Szabolcs, Matthias
    Okada, Yasunori
    D'Armiento, Jeanine
    Chada, Kiran
    CANCER RESEARCH, 2013, 73 (14) : 4289 - 4299
  • [25] IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma
    Sheen, Yi-Shuan
    Liao, Yi-Hua
    Lin, Ming-Hsien
    Chu, Chia-Ying
    Ho, Bing-Ying
    Hsieh, Meng-Chen
    Chen, Pin-Chun
    Cha, Shih-Ting
    Jeng, Yung-Ming
    Chang, Cheng-Chi
    Chiu, Hsien-Ching
    Jee, Shiou-Hwa
    Kuo, Min-Liang
    Chu, Chia-Yu
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (04) : 1065 - 1073
  • [26] The mesenchyme-specific gene HMGA2 modulates tumor progression and metastasis
    Morishita, Asahiro
    Zaidi, M. Raza
    Mitoro, Akira
    Sankarasharma, Devipriya
    Szabolcs, Matthias
    Okada, Yasunori
    D'Armiento, Jeanine
    Chada, Kiran
    CANCER RESEARCH, 2009, 69
  • [27] Osteopontin Promotes EZH2 Expression and Tumor Progression in Nasopharyngeal Carcinoma
    Ma, Renqiang
    Luo, Xi
    Feng, Shaoyan
    Li, Jian
    Fan, Yunping
    Wen, Weiping
    Li, Huabin
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2014, 76 (05): : 273 - 281
  • [28] HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma
    Palumbo, Antonio, Jr.
    Da Costa, Nathalia Meireles
    Esposito, Francesco
    De Martino, Marco
    D'Angelo, Daniela
    Leite de Sousa, Vanessa Paiva
    Martins, Ivanir
    Nasciutti, Luiz Eurico
    Fusco, Alfredo
    Ribeiro Pinto, Luis Felipe
    ONCOTARGET, 2016, 7 (18) : 25872 - 25884
  • [29] HMGA2 promotes invasion and stemness in glioblastoma
    Kaur, Harpreet
    Huett, Marianne
    Mao, Xing-gang
    Orr, Brent A.
    Eberhart, Charles G.
    Raabe, Eric H.
    CANCER RESEARCH, 2014, 74 (19)
  • [30] LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1
    Cao, Yan
    Li, Jian
    Du, Yongliang
    Sun, Yuxuan
    Liu, Le
    Fang, Hao
    Liang, Yan
    Mao, Shanshan
    FASEB JOURNAL, 2023, 37 (12):